US Drug Recall Register
Class II · Moderate risk Terminated Initiated Nov 12, 2019 (7 years ago)

Fluphenazine Decanoate Injection USP 125mg/5mL

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Discoloration; Hazy solution found in one vial instead of a clear solution.

What was recalled

Fluphenazine Decanoate Injection USP 125mg/5mL, (5 mL Multiple Dose Vial), Rx only, For IM or SC Use, Mfd in India for: AuroMedics Pharma, LLC, E. Windsor, NJ

Recalling firm
AuroMedics Pharma LLC
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0609-2020

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Fluphenazine recalls

See all
Class II · Moderate risk Ongoing

Fluphenazine Hydrochloride Tablets

Reason CGMP Deviations

Glenmark Pharmaceuticals Inc., USA NDC 68462-338-01 D-0326-2025
Class II · Moderate risk Terminated

Fluphenazine HCl active pharmaceutical ingredient packaged in…

Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Attix Pharmaceuticals D-686-2015
Class II · Moderate risk Terminated

Fluphenazine Decanoate active pharmaceutical ingredient packaged…

Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Attix Pharmaceuticals D-685-2015